Unilateral Laparoscopic TAP Block vs. Local Infiltration in Post-Cholecystectomy Analgesia
NCT ID: NCT07176299
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2021-09-14
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Oblique Subcostal, Posterior or Dual Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy
NCT04693156
Pain After Laparoscopic Cholecystectomy With Bilateral Tranversus Abdominis Plane (TAP) Block Versus Local Anesthetic Infiltration
NCT01204892
Laparoscopic-Assisted Transversus Abdominus Plane Block Versus Intraperitoneal Irrigation of Local Anesthetic for Patients Undergoing Laparoscopic Cholecystectomy
NCT06714279
"The Efficiency of Laparoscopic-assisted Transversus Abdominis Plane Block for Post-laparoscopic Cholecystectomy Pain
NCT04641403
Unilateral TAP Block vs Trocar Insertion Sites Infiltration Anesthesia in Laparoscopic Cholecystectomy
NCT03543202
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This prospective, randomized clinical trial was conducted at the University Clinical Hospital in Olsztyn, Poland. A total of 160 patients undergoing elective laparoscopic cholecystectomy were randomized into four groups: TAP block, LAI, TAP+LAI, and control. All patients received the same type of anesthesia and standard pain medications.
The primary goal was to compare pain intensity within 24 hours after surgery using the Numerical Rating Scale (NRS). Secondary measures included use of additional painkillers, recovery scores (Aldrete), and possible complications at the wound site. The influence of surgical drains and gallstone size on pain was also examined.
The study found that the unilateral laparoscopic TAP block provided the best pain relief, fewer wound-related complications, and reduced need for additional medications compared with other methods. These results suggest that the laparoscopic TAP block is a safe and effective option for improving postoperative pain management after gallbladder surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. unilateral laparoscopic TAP block,
2. local anesthetic infiltration (LAI),
3. combined TAP+LAI,
4. control (no regional anesthesia).
Each participant remained in the assigned group throughout the study.
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAP Block
Participants received a unilateral laparoscopic transversus abdominis plane (TAP) block performed under direct laparoscopic vision using 20 mL of 0.25% bupivacaine.
Unilateral laparoscopic TAP block (0.25% bupivacaine)
Injection of 20 mL 0.25% bupivacaine into the transversus abdominis plane under direct laparoscopic vision.
Local Anesthetic Infiltration (LAI)
Participants received local infiltration of 20 mL of 0.25% bupivacaine at the trocar insertion sites under laparoscopic guidance.
Local anesthetic infiltration (0.25% bupivacaine)
Injection of 20 mL 0.25% bupivacaine distributed across trocar insertion sites under laparoscopic guidance.
TAP + LAI
Participants received a combination of unilateral laparoscopic TAP block (10 mL of 0.25% bupivacaine) and local anesthetic infiltration at trocar sites (10 mL of 0.25% bupivacaine).
Combined TAP block and local anesthetic infiltration (0.25% bupivacaine)
10 mL of 0.25% bupivacaine given as a TAP block and 10 mL administered as local infiltration at trocar sites.
Control (No Regional Anesthesia)
Participants did not receive regional anesthesia. Postoperative pain management was provided only with standardized intravenous analgesics.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Unilateral laparoscopic TAP block (0.25% bupivacaine)
Injection of 20 mL 0.25% bupivacaine into the transversus abdominis plane under direct laparoscopic vision.
Local anesthetic infiltration (0.25% bupivacaine)
Injection of 20 mL 0.25% bupivacaine distributed across trocar insertion sites under laparoscopic guidance.
Combined TAP block and local anesthetic infiltration (0.25% bupivacaine)
10 mL of 0.25% bupivacaine given as a TAP block and 10 mL administered as local infiltration at trocar sites.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for elective laparoscopic cholecystectomy for symptomatic cholelithiasis confirmed by ultrasonography
* American Society of Anesthesiologists (ASA) physical status I-II
* Provided written informed consent
Exclusion Criteria
* Contraindications to laparoscopy
* Acute cholecystitis diagnosed preoperatively or perioperatively
* Chronic analgesic use
* Spinal degenerative joint disease
* Known allergy to local anesthetics
* Opioid or alcohol dependence
* Psychiatric or neurological disorders
* Lack of consent or withdrawal of consent
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Warmia and Mazury in Olsztyn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Łukasz Dyśko
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Clinical Hospital in Olsztyn
Olsztyn, Warmian-Masurian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
University of Warmia and Mazur
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.